Tag: HighTide

May 8, 2020 Off

HighTide Phase 2 in primary sclerosing cholangitis in the U.S., Canada, topline results expected in 2H2020

HighTide is expecting to finalize the data analysis and is preparing submissions for presentation and peer-reviewed publication.

May 7, 2020 Off

HighTide phase 2a Study of HTD1801 in NASH Patients meets primary endpoint

By BusinessWire

HighTide Therapeutics said that its HTD1801 met primary endpoint in Phase 2 trial with statistically significant reduction in liver fat in patients with NASH and diabetes, as HTD1801 demonstrated broad beneficial effects in measures of glycemic control, liver injury and cardiovascular risk factors.